From: Hsa-miR-375 is a predictor of local control in early stage breast cancer
 | Pilot phase | Validation phase | |||||
---|---|---|---|---|---|---|---|
miRNA | Median fold change relapse/control | Relapse (∆Ct − median) | Control (∆Ct − median) | Median fold change relapse/control | PCR efficiency | Raw p value | Corrected p value |
hsa-miR-660 | 0.77 | 5.13 | 7.31 | 4.53 | 2.00 | <0.001 | <0.001 |
hsa-miR-375 | 2.97 | 3.24 | 4.43 | 2.28 | 1.89 | 0.001 | 0.008 |
hsa-miR-125a-3p | 1.26 | 6.79 | 6.91 | 1.09 | 2.02 | 0.448 | 1.000 |
hsa-miR-362-3p | 0.80 | 7.25 | 7.82 | 1.48 | 1.98 | 0.093 | 0.744 |
hsa-miR-210 | 0.51 | 6.15 | 5.21 | 0.52 | 1.95 | 0.121 | 1.000 |
hsa-miR-223 | 0.58 | 2.81 | 3.13 | 1.25 | 1.98 | 0.806 | 1.000 |
hsa-miR-487b | 1.22 | 6.93 | 7.30 | 1.29 | 2.10 | 0.373 | 1.000 |
hsa-miR-532-3p | 0.90 | 6.22 | 6.30 | 1.05 | 2.15 | 0.679 | 1.000 |